JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120675

DPDPE, delta opioid receptor agonist

Be the first to review this product! Submit a review

|

(2 Publications)

DPDPE (CAS: 88373-73-3) is a delta opioid receptor agonist. Potent and selective δ opioid receptor agonist (Ki values are 14, >1000 and >1000 nM for opioid receptor subtypes δ, κ and µ, respectively). MW 645.79 g/mol, Purity >95.

- Available in different sizes to fit your experimental needs. Larger volume format available upon request.
1 Images
Chemical Structure - DPDPE, delta opioid receptor agonist (AB120675)
  • Chemical Structure

Lab

Chemical Structure - DPDPE, delta opioid receptor agonist (AB120675)

2D chemical structure image of ab120675, DPDPE, delta opioid receptor agonist

Key facts

CAS number

88373-73-3

Purity

>95%

Form

Solid

form

Molecular weight

645.79 g/mol

Nature

Synthetic

Solubility

Soluble in water to 1 mg/ml

Biological description

Potent and selective δ opioid receptor agonist (Ki values are 14, >1000 and >1000 nM for opioid receptor subtypes δ, κ and μ, respectively). Centrally active following systemic administration.

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Scientific reports 7:9969 PubMed28855588

2017

Morphine activation of mu opioid receptors causes disinhibition of neurons in the ventral tegmental area mediated by β-arrestin2 and c-Src.

Applications

Unspecified application

Species

Unspecified reactive species

Fiona A Bull,Daniel T Baptista-Hon,Jeremy J Lambert,Wendy Walwyn,Tim G Hales

American journal of human genetics 100:706-724 PubMed28413018

2017

PLAA Mutations Cause a Lethal Infantile Epileptic Encephalopathy by Disrupting Ubiquitin-Mediated Endolysosomal Degradation of Synaptic Proteins.

Applications

Unspecified application

Species

Unspecified reactive species

Emma A Hall,Michael S Nahorski,Lyndsay M Murray,Ranad Shaheen,Emma Perkins,Kosala N Dissanayake,Yosua Kristaryanto,Ross A Jones,Julie Vogt,Manon Rivagorda,Mark T Handley,Girish R Mali,Tooba Quidwai,Dinesh C Soares,Margaret A Keighren,Lisa McKie,Richard L Mort,Noor Gammoh,Amaya Garcia-Munoz,Tracey Davey,Matthieu Vermeren,Diana Walsh,Peter Budd,Irene A Aligianis,Eissa Faqeih,Alan J Quigley,Ian J Jackson,Yogesh Kulathu,Mandy Jackson,Richard R Ribchester,Alex von Kriegsheim,Fowzan S Alkuraya,C Geoffrey Woods,Eamonn R Maher,Pleasantine Mill
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com